S&P 500   3,662.38 (+0.00%)
DOW   29,804.27 (-0.07%)
QQQ   303.61 (+0.05%)
AAPL   123.08 (+0.29%)
MSFT   214.08 (-0.99%)
FB   289.40 (+0.99%)
GOOGL   1,822.32 (+1.50%)
AMZN   3,220.40 (+0.01%)
TSLA   563.15 (-3.70%)
NVDA   542.50 (+1.29%)
BABA   262.05 (-0.74%)
CGC   28.25 (+6.00%)
GE   10.37 (+2.17%)
MU   68.93 (+2.76%)
AMD   94.87 (+2.42%)
T   28.94 (+0.24%)
NIO   46.28 (+2.03%)
F   9.19 (-0.54%)
ACB   10.68 (+9.54%)
NFLX   504.18 (-0.08%)
BA   218.31 (+2.49%)
GILD   61.32 (+0.33%)
DIS   152.42 (+1.99%)
S&P 500   3,662.38 (+0.00%)
DOW   29,804.27 (-0.07%)
QQQ   303.61 (+0.05%)
AAPL   123.08 (+0.29%)
MSFT   214.08 (-0.99%)
FB   289.40 (+0.99%)
GOOGL   1,822.32 (+1.50%)
AMZN   3,220.40 (+0.01%)
TSLA   563.15 (-3.70%)
NVDA   542.50 (+1.29%)
BABA   262.05 (-0.74%)
CGC   28.25 (+6.00%)
GE   10.37 (+2.17%)
MU   68.93 (+2.76%)
AMD   94.87 (+2.42%)
T   28.94 (+0.24%)
NIO   46.28 (+2.03%)
F   9.19 (-0.54%)
ACB   10.68 (+9.54%)
NFLX   504.18 (-0.08%)
BA   218.31 (+2.49%)
GILD   61.32 (+0.33%)
DIS   152.42 (+1.99%)
S&P 500   3,662.38 (+0.00%)
DOW   29,804.27 (-0.07%)
QQQ   303.61 (+0.05%)
AAPL   123.08 (+0.29%)
MSFT   214.08 (-0.99%)
FB   289.40 (+0.99%)
GOOGL   1,822.32 (+1.50%)
AMZN   3,220.40 (+0.01%)
TSLA   563.15 (-3.70%)
NVDA   542.50 (+1.29%)
BABA   262.05 (-0.74%)
CGC   28.25 (+6.00%)
GE   10.37 (+2.17%)
MU   68.93 (+2.76%)
AMD   94.87 (+2.42%)
T   28.94 (+0.24%)
NIO   46.28 (+2.03%)
F   9.19 (-0.54%)
ACB   10.68 (+9.54%)
NFLX   504.18 (-0.08%)
BA   218.31 (+2.49%)
GILD   61.32 (+0.33%)
DIS   152.42 (+1.99%)
S&P 500   3,662.38 (+0.00%)
DOW   29,804.27 (-0.07%)
QQQ   303.61 (+0.05%)
AAPL   123.08 (+0.29%)
MSFT   214.08 (-0.99%)
FB   289.40 (+0.99%)
GOOGL   1,822.32 (+1.50%)
AMZN   3,220.40 (+0.01%)
TSLA   563.15 (-3.70%)
NVDA   542.50 (+1.29%)
BABA   262.05 (-0.74%)
CGC   28.25 (+6.00%)
GE   10.37 (+2.17%)
MU   68.93 (+2.76%)
AMD   94.87 (+2.42%)
T   28.94 (+0.24%)
NIO   46.28 (+2.03%)
F   9.19 (-0.54%)
ACB   10.68 (+9.54%)
NFLX   504.18 (-0.08%)
BA   218.31 (+2.49%)
GILD   61.32 (+0.33%)
DIS   152.42 (+1.99%)
Log in
ARCA:TMBR

Timber Pharmaceuticals Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume508,219 shs
Market Capitalization$12.51 million
P/E RatioN/A
Dividend YieldN/A
Beta0.07
Timber Pharmaceuticals LLC, a clinical-stage medical dermatology company, focuses on the development and commercialization of pharmaceuticals for treatment of orphan dermatologic diseases. The company was founded in 2019 and is based in Woodcliff Lake, New Jersey.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.00 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone973 314 9570
Employees6

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$60,000.00
Book Value($0.22) per share

Profitability

Net Income$-9,690,000.00

Miscellaneous

Market Cap$12.51 million
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive TMBR News and Ratings via Email

Sign-up to receive the latest news and ratings for TMBR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Timber Pharmaceuticals (ARCA:TMBR) Frequently Asked Questions

What stocks does MarketBeat like better than Timber Pharmaceuticals?

Wall Street analysts have given Timber Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Timber Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Timber Pharmaceuticals' key competitors?

Who are Timber Pharmaceuticals' key executives?

Timber Pharmaceuticals' management team includes the following people:
  • Mr. Michael Derby M.B.A., M.S., Exec. Chairman (Age 47)
  • Mr. John Koconis M.B.A., CEO & Director (Age 50)
  • Mr. Zachary Rome, Pres, COO, Exec. VP, Sec. & Director (Age 36)
  • Mr. Joseph Lucchese, Exec. VP & CFO (Age 53)
  • Dr. Amir Tavakkol, Chief Scientific Officer (Age 65)

What is Timber Pharmaceuticals' stock symbol?

Timber Pharmaceuticals trades on the ARCA under the ticker symbol "TMBR."

How do I buy shares of Timber Pharmaceuticals?

Shares of TMBR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

How big of a company is Timber Pharmaceuticals?

Timber Pharmaceuticals has a market capitalization of $0.00 and generates $60,000.00 in revenue each year. Timber Pharmaceuticals employs 6 workers across the globe.

What is Timber Pharmaceuticals' official website?

The official website for Timber Pharmaceuticals is www.timberpharma.com.

How can I contact Timber Pharmaceuticals?

The company can be reached via phone at 973 314 9570.

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.